Apr 26, 2018 12:01 pm UTC| Business
BOULDER, Colo., April 26, 2018 -- FreeWave Technologies, a leader in industrial, secure Machine-to-Machine (M2M) and Industrial Internet of Things (IIoT) networking solutions, today announced a technology partnership...
IsoRay Announces Third Quarter Fiscal 2018 Earnings Conference Call
Apr 26, 2018 12:01 pm UTC| Business
RICHLAND, Wash., April 26, 2018 -- IsoRay, Inc. (the “Company”) (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate,...
Avid Transforms TV News Production for RTS Senegal Africa
Apr 26, 2018 12:01 pm UTC| Business
BURLINGTON, Mass., April 26, 2018 -- Avid® (Nasdaq: AVID), the platform that powers media and entertainment, today announced that RTS, a public news broadcaster in Senegal, has transformed its infrastructure by...
Apr 26, 2018 12:01 pm UTC| Business
Phase 1/2 clinical trial in patients with Parkinson's disease (PD) expanded to add additional cohort. NEW YORK, April 26, 2018 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on...
CAB Financial Corporation Reports its First Quarter 2018 Results
Apr 26, 2018 12:01 pm UTC| Business
SPARTANBURG, S.C., April 26, 2018 -- CAB Financial Corporation (OTCQX:CABF) (the “Corporation”), holding company for Carolina Alliance Bank, today reported 2018 first quarter consolidated financial results. Net income...
Blucora to Announce First Quarter 2018 Financial Results Wednesday, May 9, 2018
Apr 26, 2018 12:01 pm UTC| Business
IRVING, Texas, April 26, 2018 -- Blucora, Inc. (NASDAQ:BCOR), a leading provider of technology-enabled financial solutions to consumers, small businesses and tax professionals, will announce its first quarter 2018...
Corbus Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference
Apr 26, 2018 12:01 pm UTC| Business
NORWOOD, Mass., April 26, 2018 -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), a clinical-stage drug development company targeting rare, chronic, serious inflammatory and fibrotic...